GAM Holding’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$4.17M Sell
11,893
-513
-4% -$173K 0.27% 97
2025
Q3
$4.01M Sell
12,406
-64
-0.5% -$19.9K 0.25% 101
2025
Q2
$4.85M Buy
12,470
+53
+0.4% +$21.3K 0.34% 83
2025
Q1
$5.4M Sell
12,417
-2,292
-16% -$920K 0.42% 73
2024
Q4
$5.43M Sell
14,709
-1,032
-7% -$432K 0.4% 64
2024
Q3
$8.19M Buy
15,741
+121
+0.8% +$64.6K 0.65% 51
2024
Q2
$8.46M Buy
15,620
+51
+0.3% +$27K 0.65% 53
2024
Q1
$8.07M Buy
15,569
+65
+0.4% +$32.3K 0.58% 60
2023
Q4
$7.31M Hold
15,504
0.54% 67
2023
Q3
$6.75M Sell
15,504
-12
-0.1% -$5.44K 0.5% 67
2023
Q2
$6.89M Sell
15,516
-26
-0.2% -$12K 0.48% 69
2023
Q1
$7.15M Sell
15,542
-325
-2% -$155K 0.5% 68
2022
Q4
$8.14M Sell
15,867
-147
-0.9% -$74.6K 0.65% 56
2022
Q3
$7.27M Sell
16,014
-6,515
-29% -$3.12M 0.56% 61
2022
Q2
$10.9M Buy
22,529
+563
+3% +$279K 0.72% 39
2022
Q1
$10.8M Buy
21,966
+2,812
+15% +$1.29M 0.53% 62
2021
Q4
$8.88M Sell
19,154
-17
-0.1% -$7.15K 0.4% 76
2021
Q3
$7.15M Sell
19,171
-1,807
-9% -$687K 0.33% 92
2021
Q2
$8.01M Sell
20,978
-754
-3% -$288K 0.35% 96
2021
Q1
$7.8M Buy
21,732
+8,847
+69% +$2.85M 0.36% 83
2020
Q4
$4.14M Buy
+12,885
New +$3.95M 0.25% 114
2019
Q4
Sell
-2,556
Closed -$613K 626
2019
Q3
$613K Sell
2,556
-892
-26% -$244K 0.03% 524
2019
Q2
$973K Sell
3,448
-1,428
-29% -$390K 0.04% 499
2019
Q1
$1.4M Buy
4,876
+593
+14% +$172K 0.06% 329
2018
Q4
$1.12M Sell
4,283
-652
-13% -$179K 0.06% 331
2018
Q3
$1.35M Sell
4,935
-1,388
-22% -$360K 0.05% 381
2018
Q2
$1.5M Sell
6,323
-1,029
-14% -$238K 0.05% 347
2018
Q1
$1.61M Sell
7,352
-4,028
-35% -$946K 0.06% 332
2017
Q4
$2.58M Buy
+11,380
New +$2.42M 0.08% 300
2017
Q3
Sell
-40,423
Closed -$7.61M 659
2017
Q2
$7.61M Buy
40,423
+193
+0.5% +$34.7K 0.11% 230
2017
Q1
$6.65M Buy
40,230
+5,603
+16% +$891K 0.11% 234
2016
Q4
$4.98M Buy
34,627
+1,115
+3% +$149K 0.09% 265
2016
Q3
$4.2M Sell
33,512
-292
-0.9% -$37.7K 0.07% 296
2016
Q2
$4.44M Sell
33,804
-5,162
-13% -$706K 0.07% 330
2016
Q1
$5.42M Sell
38,966
-36,600
-48% -$4.89M 0.09% 254
2015
Q4
$10.5M Sell
75,566
-7,174
-9% -$988K 0.16% 156
2015
Q3
$11.6M Sell
82,740
-7,929
-9% -$1.19M 0.2% 138
2015
Q2
$14.9M Buy
90,669
+15,652
+21% +$2.5M 0.22% 134
2015
Q1
$11.6M Sell
75,017
-1,796
-2% -$256K 0.17% 149
2014
Q4
$9.65M Buy
76,813
+798
+1% +$98.6K 0.14% 183
2014
Q3
$9.09M Sell
76,015
-1,500
-2% -$172K 0.13% 195
2014
Q2
$8.34M Buy
77,515
+10,300
+15% +$1.06M 0.13% 196
2014
Q1
$6.69M Buy
67,215
+9,263
+16% +$838K 0.11% 222
2013
Q4
$5.35M Sell
57,952
-5,400
-9% -$480K 0.09% 243
2013
Q3
$5.3M Sell
63,352
-24,400
-28% -$2.09M 0.1% 240
2013
Q2
$7.18M Buy
+87,752
New +$6.57M 0.16% 180

Other funds holding ELV

GAM Holding's ELV Position: Q4 2025 in Review

GAM Holding reduced its Elevance Health (ELV) stake by 4.1% in Q4 2025, selling an estimated $173K and leaving 11,893 shares worth $4.17M. The position accounts for 0.27% of the portfolio, ranked #97.

GAM Holding first reported a position in ELV in Q2 2013 and has held it in 46 quarters since. The position peaked at $14.9M in Q2 2015. 1,554 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • GAM Holding held 11,893 shares of Elevance Health worth $4.17M as of Q4 2025.
  • GAM Holding sold 513 Elevance Health shares in Q4 2025, an estimated $173K.
  • Elevance Health made up 0.27% of GAM Holding's portfolio in Q4 2025, its #97 holding.
  • GAM Holding first reported a position in Elevance Health in Q2 2013 and has held it in 46 quarters since.
  • GAM Holding's Elevance Health position peaked at $14.9M in Q2 2015.
  • 1,554 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on GAM Holding's 13F filing for Q4 2025, filed 17 Feb 2026.